Bill Status of SB 345   99th General Assembly

Short Description:  AUTISM AWARENESS ACT

Senate Sponsors
Sen. Don Harmon, Antonio Muņoz, Heather A. Steans, John J. Cullerton-Ira I. Silverstein-Linda Holmes-Jacqueline Y. Collins-Kimberly A. Lightford, John G. Mulroe, William Delgado and Michael Noland

House Sponsors
(Rep. Jay Hoffman-Barbara Flynn Currie-Robyn Gabel-Patricia R. Bellock-Cynthia Soto, Stephanie A. Kifowit, Deb Conroy, Sue Scherer, La Shawn K. Ford, Emanuel Chris Welch, Will Guzzardi, Mike Fortner, Carol Ammons, William Davis, Frances Ann Hurley, Martin J. Moylan, Dan Brady, Lawrence Walsh, Jr., Mary E. Flowers, Eddie Lee Jackson, Sr., Sara Wojcicki Jimenez, Grant Wehrli and Camille Y. Lilly)


Last Action  View All Actions

DateChamber Action
  8/12/2016SenatePublic Act . . . . . . . . . 99-0788

Statutes Amended In Order of Appearance
405 ILCS 5/3-101from Ch. 91 1/2, par. 3-101

Synopsis As Introduced
Amends the Mental Health and Developmental Disabilities Code. Makes a technical change in a Section concerning State's Attorneys' representation of the State in court proceedings.

Senate Floor Amendment No. 2
Deletes reference to:
405 ILCS 5/3-101
Adds reference to:
New Act
215 ILCS 5/356z.14
215 ILCS 5/356z.24 new

Replaces everything after the enacting clause. Creates the Autism and Co-Occurring Medical Conditions Awareness Act. Contains legislative findings. Defines terms. Provides that specified research shall be encouraged and disseminated to entities that may contribute to the scientific understanding of conditions that co-occur with autism spectrum disorders. Encourages specified entities to develop continuing education courses for providers who treat persons with autism spectrum disorders. Encourages providers to evaluate a person diagnosed with an autism spectrum disorder for co-occurring conditions in specified circumstances. Provides that providers may consider whether specified substances may exacerbate an autism spectrum disorder or co-occurring condition and adopt appropriate measures to reduce such risks. Provides that any person with an autism spectrum disorder or their parent or guardian that believes they have received inadequate care because of a co-occurring condition may report such treatment to the Department of Financial and Professional Regulation. Contains provisions concerning a person with an autism spectrum disorder or their parent or guardian's right to seek additional care. Provides for the Act's repeal 5 years after the effective date. Amends the Illinois Insurance Code. Provides that an insurer may not require, as a condition for coverage of other covered services, that an individual diagnosed with an autism spectrum disorder receive any medication or intervention that has been determined by the individual's health care provider to be medically contraindicated for the individual. An insurer may not deny or refuse to provide covered services, or refuse to renew, refuse to reissue, or otherwise terminate or restrict coverage under an individual contract, for a person diagnosed with an autism spectrum disorder on the basis that the individual declined an alternative medication or covered service when the individual's health care provider determined that such medication or covered service may exacerbate clinical symptomatology and is medically contraindicated for the individual. Provides that a group or individual policy of accident and health insurance or managed care plan amended, delivered, issued, or renewed after the effective date of the amendatory Act may not allow for the delay, discontinuation, or interruption of immune gamma globulin therapy for persons who are diagnosed with a primary immunodeficiency when prescribed immune gamma globulin therapy by a physician licensed to practice medicine in all of its branches. Effective immediately.

Senate Floor Amendment No. 4
Deletes reference to:
405 ILCS 5/3-101from Ch. 91 1/2, par. 3-101
Adds reference to:
New Act
215 ILCS 5/356z.14
215 ILCS 5/356z.24 new

Replaces everything after the enacting clause. Creates the Autism and Co-Occurring Medical Conditions Awareness Act. Contains legislative findings. Defines terms. Provides that specified research shall be encouraged and disseminated to entities that may contribute to the scientific understanding of conditions that co-occur with autism spectrum disorders. Encourages specified entities to develop continuing education courses for providers who treat persons with autism spectrum disorders. Encourages providers to evaluate a person diagnosed with an autism spectrum disorder for co-occurring conditions in specified circumstances. Provides that providers may consider whether specified substances may exacerbate an autism spectrum disorder or co-occurring condition and adopt appropriate measures to reduce such risks. Provides that any person with an autism spectrum disorder or their parent or guardian that believes they have received inadequate care because of a co-occurring condition may report such treatment to the Department of Financial and Professional Regulation. Contains provisions concerning a person with an autism spectrum disorder or their parent or guardian's right to seek additional care. Provides for the Act's repeal 5 years after the effective date. Amends the Illinois Insurance Code. Provides that an insurer may not deny or refuse to provide covered services, or refuse to renew, refuse to reissue, or otherwise terminate or restrict coverage under an individual contract, for a person diagnosed with an autism spectrum disorder on the basis that the individual declined an alternative medication or covered service when the individual's health care provider determined that such medication or covered service may exacerbate clinical symptomatology and is medically contraindicated for the individual and the individual has requested and received a medical exception as provided under a provision of the Managed Care Reform and Patient Rights Act. Provides that a group or individual policy of accident and health insurance or managed care plan amended, delivered, issued, or renewed after the effective date of the amendatory Act may not allow for the delay, discontinuation, or interruption of immune gamma globulin therapy for persons who are diagnosed with a primary immunodeficiency when prescribed immune gamma globulin therapy by a physician licensed to practice medicine in all of its branches if provided as a covered benefit under the plan. Sets forth a provision concerning authorization and reauthorization. Provides that the provisions concerning coverage for immune gamma globulin treatment are inoperative with respect to all outlined coverage other than that authorized under Section 1902 of the Social Security Act and the State shall not assume any obligation for the cost of the coverage set forth if, at any time, the Secretary of the United States Department of Health and Human Services, or its successor agency, promulgates rules or regulations to be published in the Federal Register or publishes a comment in the Federal Register or issues an opinion, guidance, or other action that would require the State, pursuant to any provision of the Patient Protection and Affordable Care Act, to defray the cost of the outlined coverage. Effective immediately.

Actions 
DateChamber Action
  1/28/2015SenateFiled with Secretary by Sen. John J. Cullerton
  1/28/2015SenateFirst Reading
  1/28/2015SenateReferred to Assignments
  3/18/2015SenateAssigned to Executive
  3/26/2015SenateDo Pass Executive; 016-000-000
  3/26/2015SenatePlaced on Calendar Order of 2nd Reading April 14, 2015
  4/15/2015SenateSecond Reading
  4/15/2015SenatePlaced on Calendar Order of 3rd Reading April 16, 2015
  4/21/2015SenateRe-referred to Assignments
  3/8/2016SenateApproved for Consideration Assignments
  3/8/2016SenatePlaced on Calendar Order of 3rd Reading March 9, 2016
  3/16/2016SenateChief Sponsor Changed to Sen. Don Harmon
  4/15/2016SenateSenate Floor Amendment No. 1 Filed with Secretary by Sen. Don Harmon
  4/15/2016SenateSenate Floor Amendment No. 1 Referred to Assignments
  4/18/2016SenateAdded as Co-Sponsor Sen. Antonio Muņoz
  4/18/2016SenateAdded as Co-Sponsor Sen. Heather A. Steans
  4/19/2016SenateSenate Floor Amendment No. 1 Assignments Refers to Insurance
  4/19/2016SenateAdded as Co-Sponsor Sen. John J. Cullerton
  4/19/2016SenateAdded as Chief Co-Sponsor Sen. Ira I. Silverstein
  4/19/2016SenateAdded as Co-Sponsor Sen. Linda Holmes
  4/19/2016SenateSponsor Removed Sen. Linda Holmes
  4/20/2016SenateAdded as Chief Co-Sponsor Sen. Linda Holmes
  4/20/2016SenateAdded as Chief Co-Sponsor Sen. Jacqueline Y. Collins
  4/20/2016SenateAdded as Chief Co-Sponsor Sen. Kimberly A. Lightford
  4/20/2016SenateAdded as Co-Sponsor Sen. John G. Mulroe
  4/20/2016SenateSenate Floor Amendment No. 1 Postponed - Insurance
  4/21/2016SenateAdded as Co-Sponsor Sen. William Delgado
  4/22/2016SenateRule 2-10 Committee/3rd Reading Deadline Established As May 13, 2016
  5/5/2016SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. Don Harmon
  5/5/2016SenateSenate Floor Amendment No. 2 Referred to Assignments
  5/5/2016SenateSenate Floor Amendment No. 2 Assignments Refers to Insurance
  5/10/2016SenateSenate Floor Amendment No. 2 Recommend Do Adopt Insurance; 009-000-000
  5/13/2016SenateRule 2-10 Committee/3rd Reading Deadline Established As May 27, 2016
  5/18/2016SenateSenate Floor Amendment No. 3 Filed with Secretary by Sen. Don Harmon
  5/18/2016SenateSenate Floor Amendment No. 3 Referred to Assignments
  5/18/2016SenateSenate Floor Amendment No. 4 Filed with Secretary by Sen. Don Harmon
  5/18/2016SenateSenate Floor Amendment No. 4 Referred to Assignments
  5/19/2016SenateSenate Floor Amendment No. 3 Pursuant to Senate Rule 3-8(b-1), this amendment will remain in the Committee on Assignments
  5/19/2016SenateSenate Floor Amendment No. 4 Be Approved for Consideration Assignments
  5/19/2016SenateRecalled to Second Reading
  5/19/2016SenateSenate Floor Amendment No. 2 Adopted; Harmon
  5/19/2016SenateSenate Floor Amendment No. 4 Adopted; Harmon
  5/19/2016SenateAdded as Co-Sponsor Sen. Michael Noland
  5/19/2016SenatePlaced on Calendar Order of 3rd Reading
  5/19/2016SenateThird Reading - Passed; 055-000-000
  5/19/2016SenateSenate Floor Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
  5/19/2016SenateSenate Floor Amendment No. 3 Tabled Pursuant to Rule 5-4(a)
  5/20/2016HouseArrived in House
  5/20/2016HouseChief House Sponsor Rep. Jay Hoffman
  5/23/2016HouseFirst Reading
  5/23/2016HouseReferred to Rules Committee
  5/23/2016HouseAssigned to Human Services Committee
  5/23/2016HouseFinal Action Deadline Extended-9(b) May 31, 2016
  5/24/2016HouseAdded Alternate Chief Co-Sponsor Rep. Barbara Flynn Currie
  5/29/2016HouseAdded Alternate Chief Co-Sponsor Rep. Robyn Gabel
  5/29/2016HouseDo Pass / Short Debate Human Services Committee; 011-000-000
  5/29/2016HousePlaced on Calendar 2nd Reading - Short Debate
  5/29/2016HouseSecond Reading - Short Debate
  5/29/2016HouseHeld on Calendar Order of Second Reading - Short Debate
  5/30/2016HousePlaced on Calendar Order of 3rd Reading - Short Debate
  5/30/2016HouseThird Reading - Short Debate - Passed 117-000-000
  5/30/2016HouseAdded Alternate Chief Co-Sponsor Rep. Patricia R. Bellock
  5/30/2016HouseAdded Alternate Chief Co-Sponsor Rep. Cynthia Soto
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Stephanie A. Kifowit
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Deb Conroy
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Sue Scherer
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. La Shawn K. Ford
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Emanuel Chris Welch
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Will Guzzardi
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Mike Fortner
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Carol Ammons
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. William Davis
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Frances Ann Hurley
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Martin J. Moylan
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Dan Brady
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Lawrence Walsh, Jr.
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Mary E. Flowers
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Eddie Lee Jackson, Sr.
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Sara Wojcicki Jimenez
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Grant Wehrli
  5/30/2016HouseAdded Alternate Co-Sponsor Rep. Camille Y. Lilly
  5/30/2016SenatePassed Both Houses
  6/28/2016SenateSent to the Governor
  8/12/2016SenateGovernor Approved
  8/12/2016SenateEffective Date August 12, 2016
  8/12/2016SenatePublic Act . . . . . . . . . 99-0788

Back To Top